INSULIN STIMULATES GLUCOSE UTILIZATION by skeletal muscle in a dose-responsive manner (4, 13, 26, 28) . It is generally considered that substantial control over this response resides within the proximal steps of metabolism, these being delivery, transmembrane transport, and trapping of glucose within muscle by phosphorylation. Of these, glucose transport is regarded as the pivotal locus of control. This concept is based on the molecular physiology of insulin-stimulated translocation of GLUT4 proteins (23) , findings obtained in animal studies and cell culture systems (17, 20) , and absence of the accumulation of free glucose in muscle during stepwise increases in insulin (14) . Estimations of free glucose in skeletal muscle performed using nuclear magnetic resonance spectroscopy during insulin-stimulated conditions in animals and in humans also indicate minimal accumulation (6, 7) . These findings support the concept that glucose transport limits insulin-stimulated glucose utilization in muscle, but the findings are also consistent with limitation at the preceding step, that of glucose delivery. Blood flow and substrate delivery are considered to have more control over rates of substrate uptake when tissue permeability is heightened and less effect when the fractional extraction is low (22) . In this regard, GLUT4-mediated glucose transport might be regarded as a "permeability" factor. Animal studies have indicated that insulin-mediated activation of glucose transport in muscle does distribute control over rates of glucose uptake toward delivery (10, 11) .
Analysis of the kinetics of a minute mass of tracer introduced during steady-state conditions can provide insight into the rates of metabolic reactions that underlie steady-state substrate flux. In the current study, steady-state euglycemic insulin clamp conditions were combined with dynamic positron emission tomography (PET) imaging to obtain temporal resolution and organ-specific measurements of 3-O-methyl- [ 11 C]glucose (3-[ 11 C]OMG) tracer activity in the tissue bed of human skeletal muscle. Because 3-OMG is not metabolized, this tracer isolates the step of bidirectional transmembrane glucose transport (5), although when used in vivo there is the added component of tracer delivery from plasma to tissue. Bonadonna et al. (4) used a brachial artery injection of 3-[ 14 C]OMG and measured the venous washout curve across the forearm in healthy volunteers at multiple doses of insulin stimulation. Dose-responsive increases in the rate constant ascribed to the step of glucose transport were observed (4) . The glucose analog deoxy-[
18 F]glucose has been used with dynamic PET imaging to study the kinetics of glucose uptake into skeletal muscle (15, 16, 21) ; however, it remains uncertain whether separate estimations of delivery, transport, and phosphorylation can be obtained from the activity curve of a single tracer (2) . A recent study from our laboratory (3) demonstrated technical feasibility in using 3-[ 11 C]OMG for PET imaging of human skeletal muscle during basal and insulin-stimulated conditions. Spectral analysis (SA) indicated that tissue tracer activity represented the interaction of two kinetic processes (3). These two processes were interpreted to represent the sequential steps of glucose delivery and transport (3) . To extend this line of investigation, the current study was undertaken to examine dose-response effects of insulin on the uptake of 3-[
11 C]OMG and to compare tracer activity in soleus, a pre-dominately oxidative muscle, with tibialis anterior, a predominately glycolytic fiber type muscle.
METHODS
Research volunteers. Lean, healthy young adults were recruited by advertisement in the general community. Before participating, each volunteer had medical and laboratory examinations to verify good health. Informed, written consent was obtained, and the University of Pittsburgh Institutional Review Board reviewed and approved this clinical investigation.
Hyperinsulinemic euglycemic clamp. Research volunteers were admitted to the University of Pittsburgh General Clinical Research Center on the evening before PET studies, received dinner, and then fasted overnight. Volunteers had been instructed to refrain from exercise on the day of admission. On the following morning, a catheter was placed in an antecubital vein for infusions and in a radial artery for blood sampling. To study insulin-stimulated metabolism, a two-step insulin infusion was used, infusing insulin at 30 mU ⅐ min Ϫ1 ⅐ m Ϫ2 (LO) for 3 h followed by 120 mU ⅐ min Ϫ1 ⅐ m Ϫ2 (HI) for 3 h. To study fasting metabolism (Basal), insulin was not infused; these results have been reported earlier (3). Arterial glucose was measured at 5-min intervals, and euglycemia was maintained using an adjustable infusion of 20% dextrose. Samples were obtained for determinations of insulin and fatty acids at baseline and hourly thereafter. Plasma glucose was measured using a YSI Glucose Analyzer (Yellow Springs, OH); plasma insulin was measured using a radioimmunoassay, and plasma fatty acids were measured using a colorimetric enzymatic assay (NEFA C test kit; Wako Chemicals, Richmond, VA).
PET image acquisition. Dynamic PET imaging of tissue activity of 3-[
11 C]OMG in skeletal muscle was performed for 90 min at Basal, LO, and HI and was carried out at the University of Pittsburgh PET Center. A Siemens/CTI ECAT HRϩ PET scanner in 3-D imaging mode (63 parallel planes; axial field of view 15.2 cm; slice width 2.4 mm), was used. The final reconstructed PET image resolution was ϳ6 mm. Volunteers were positioned in the PET scanner so that the midcalf corresponded to the midpoint axial field of view. To minimize movement during scanning and to prevent compression of muscle tissue, the legs were supported by foam blocking at the ankles and knees. Radiosynthesis of 3-[ 11 C]OMG was performed as previously described (3) . PET imaging (36 frames: 8 ϫ 15 s, 8 ϫ 15 s, 4 ϫ 1 min, 16 ϫ 5 min) began 1 h after the onset of insulin infusion simultaneously with the injection of 5 mCi of 3-[ 11 C]OMG, administered over 20 s. Blood for measuring the arterial 3-[ 11 C]OMG activity curve was obtained manually, drawing 0.5-ml samples from the radial artery catheter (10 samples every 6 s, 8 samples every 15 s, 7 samples every 1 min, 10 samples every 5 min, and 3 samples every 10 min). Each blood sample was immediately centrifuged, and 200 l of plasma were removed for immediate 11 C counting using a COBRA AutoGamma model 5003 gamma counter (Packard Instruments, Meriden, CT). The PET data were corrected for radioactive decay and scatter (24) .
On the same day, by use of the same alignment of foam blocking at the ankles and knees, a T1-weighted MRI of the midcalf was obtained. MRI was obtained only on participants in the two-step insulin infusion.
Analysis of PET images. PET and MRI were aligned using a previously described method (18, 27) . Briefly, summation PET images were created from the frames of the initial 15 min of the scanning period and coregistered with MRI, so that precise anatomic alignment was achieved. By use of the coregistered MR image, a region of interest (ROI) was placed on skeletal muscle, avoiding major vessels and the bones of the lower leg, as earlier described (3) . ROIs were also placed on anterior tibialis and soleus muscles, as shown in Fig. 1 .
3-[
11 C]OMG activity within an ROI is termed "tissue activity" and represents tracer within extracellular and intracellular spaces. Tissue activity was measured in each of the 36 frames for a given ROI, across the middle 50 of the 63 planes. Tissue activity was converted to units of radioactivity concentration (Ci/ml) using an empirical phantombased calibration factor (Ci/ml per PET counts per pixel). The tissue-to-plasma ratio (TPR) for tracer activity, the quotient of tissue to arterial radioactivity (each in units of Ci/ml), at each time was calculated and plotted for a qualitative examination of the kinetics of 3-[ 11 C]OMG uptake. Spectral analysis. Tissue activity was analyzed with SA (15), which describes this as the sum of M components, consisting of the convolution integrals of the arterial tracer activity (input function) with decaying exponentials: A ie
Ϫait . The number of components, M, yields the number of compartments needed to describe the system with a compartmental model and starts by using M ϭ 1, estimating amplitudes and eigenvalues of the decaying exponential, and then tries M ϭ 2, and so on. Akaike information criteria (AIC) were used to derive the optimal M on the basis of the principle of parsimony, i.e., the fewest number of parameters that can best fit the data. AIC is computed as AIC ϭ Nln WRSS(p ) ϩ 2P, where N is the number of PET frames (observations), P is the number of parameters, and WRSS(p ) is the weighted residual sum of squares evaluated in correspondence to the estimated value of P, p . The model of choice is associated with the lowest AIC value.
Compartmental model. Compartmental modeling was next used to examine the kinetics of tissue tracer activity, using a model comprising a plasma compartment (i.e., the measured arterial activity) and two tissue compartments, developed on the basis of SA results as earlier described (3). The compartment model is described mathematically by the following equations: Fig. 1 . MRI (A) and PET (B) images were carefully co-registered, and regions of interest (ROIs) were drawn within tibialis anterior and soleus muscle groups. ROIs were then applied to PET images to determine radioactivity accumulation within specific muscle groups. (2) . Vb (blood volume) estimates were negligible (data not shown), and Cb, tracer radioactivity in blood, was calculated from Cp [Cb ϭ Cp ⅐ (1 -0.3 ⅐ hemoglobin)] (in g/dl) (8) . From this model, the partition coefficient for 3-[
11 C]OMG between plasma and tissue can be calculated: a parameter that in PET nomenclature is commonly referred to as the tracer "volume of distribution (V d)" and is expressed in units of milliliters of plasma to milliliters of tissue (12) . Vd is not an anatomically precise volume but rather a conceptual volume that the tracer would need to occupy in tissue if the tracer were present in tissue at the same concentration as measured in plasma (12) . V d can be subdivided into a partition coefficient for each of the two compartments, termed the intracellular (Vic) and extracellular volumes of distribution (Vec). Again, neither term describes an anatomic volume but rather the partition coefficient for the tracer into these compartments.
V ic is calculated as
Vec is calculated as
The sum of Vic and Vec is Vd:
Statistics. Means Ϯ SE are reported. A paired t-test (two-tailed) was used to examine for within-subject differences between LO and HI clamp studies. ANOVA was used to examine for significance of differences in comparing Basal, LO, and HI as well as differences between muscle groups. P Ͻ 0.05 was considered to be significant.
RESULTS

Systemic glucose metabolism.
The clinical characteristics of the lean, healthy adults are shown in Table 1 . Metabolic parameters during the PET studies are shown in Table 2 Fig. 2A . Higher tissue activity was present during LO and HI compared with Basal, and there was a change in the shape of tissue activity curves. Qualitatively, during Basal conditions there was an initial brisk increase in tissue activity followed by a concavity that was not evident during LO or HI. TPR plots are shown in Fig. 2B and reveal dose-dependent insulin stimulation.
SA was used to examine which among a one-, two-, or three-exponential equation achieved the best statistical fit to tissue activity, assessed on the basis of the lowest AIC value. A three-exponential model yielded a high AIC value and low precision in parameter estimation (i.e., coefficient of variation, Ͼ100%), confirming our earlier report (3), and was not further considered. AIC values were lower with a two-exponential than a one-exponential equation. This was evident during Basal (Ϫ5.74 Ϯ 0.31 vs. Ϫ4.12 Ϯ 0.31, P Ͻ 0.001), LO (Ϫ5.30 Ϯ 0.34 vs. Ϫ4.15 Ϯ 0.67, P Ͻ 0.001), and HI (Ϫ5.55 Ϯ 0.38 vs. Ϫ4.87 Ϯ 0.67, P Ͻ 0.01) conditions. These findings indicate that a compartment model with two tissue compartments is more appropriate than one with a single compartment. However, it is of interest that, in comparing a one-with a twoexponential model, differences in AIC values were greatest during Basal and narrowed during LO and HI. Closer approximation between a one-and a two-exponential model in fitting tissue activity during LO and HI compared with Basal conditions suggests accelerated tracer exchange during insulin-stimulated conditions. 
movement of 3-[
11 C]OMG from the first into the second compartment and is attributed to inward transmembrane glucose transport. k 3 increased sixfold from Basal to LO (P Ͻ 0.001) and another threefold from LO to HI (P Ͻ 0.01). Thus, during Basal conditions, ϳ1% per minute of [ 11 C]3-OMG within the first compartment entered the second compartment, and this increased to ϳ7% per minute during LO and to ϳ21% per minute during HI. k 4 describes egress from the second to the first tissue compartment, and this rate constant increased significantly with insulin, about threefold from Basal through to HI. The error of estimation for k 1 and k 4 remained low during LO and HI but increased for k 2 (P Ͻ 0.05) and k 3 (P Ͻ 0.01) compared with Basal.
The rate constants were used to calculate the partition coefficient for 3- Fig. 3 and were calculated using the rate constants and the measured tracer activity in plasma and tissue. Compared with Basal, 3-[ 11 C]OMG activity in the second tissue compartment increased more rapidly during LO and HI, whereas tracer activity in the first tissue compartment decreased more rapidly. These plots illustrate that the main effect of insulin was to accelerate exchange of 3-[ 11 C]OMG between the first and second compartments.
3-[ 11 C]OMG tracer activity in soleus and tibialis anterior. A comparison of 3-[
11 C]OMG tracer activity in soleus and tibialis anterior muscles was made to explore the potential influence of muscle fiber type (predominantly oxidative vs. predominantly glycolytic). Muscle-specific data, obtained by coregistration of PET with MRI, were available only for LO and HI. TPR plots revealed higher 3- Mean values for the rate constants for soleus and tibialis anterior muscle are shown in Table 4 . The key difference between soleus and tibialis anterior muscle is that values for k 1 are higher in soleus muscle. In both muscles, values for k 1 remained stable at HI compared with LO. Apart from k 1 , there were no significant differences between soleus and tibialis anterior muscles for the remaining three rate constants at either LO or HI.
DISCUSSION
In the current study, dynamic PET imaging was used to examine the effect of insulin on uptake of 3-[
11 C]OMG into skeletal muscle in lean, healthy research volunteers. Doseresponsive increases were observed. 3-OMG is a transportspecific tracer and does not undergo additional metabolism (5) . Accordingly, tracer activity in tissue beds of skeletal muscle measured during PET imaging represents 3-[ 11 C]OMG that is either within interstitial space or within myocytes. Spectral analysis was performed to deconvolute tissue activity curves for 3-[
11 C]OMG with respect to arterial activity. This mathematical approach does not contain a priori assumptions about either tissue characteristics (e.g., interstitial and intracellular spaces) or metabolic processes. In the present study, SA identified that a two-exponential equation achieved a more robust fit than either a single-exponential equation or one with more than two exponentials. Taking this into account, we analyzed the tissue activity curves for 3-[ 11 C]OMG by using a model with two compartments.
On the basis of the modeling of tissue activity, there were three key findings of the present study. The first was that in healthy volunteers insulin strongly stimulates exchange of 3-[
11 C]OMG between the first and second compartments. This effect was manifested by dose-responsive insulin-stimulated increases in the rate constant k 3 . Compared with basal conditions, values for k 3 increased sixfold at a low physiological level of insulin stimulation and 20-fold at a supraphysiological level. Based on the fact that metabolism of 3-[
11 C]OMG is restricted to transport, our interpretation is that this robust effect reflects insulin stimulation of bidirectional, transmembrane glucose transport in skeletal muscle of healthy, lean men and women. This is consistent with the tenet that glucose transport is an important locus of insulin action and in the control of glucose uptake into skeletal muscle (20, 23) . The second finding was that insulin did not significantly change values for k 1 , the rate constant describing tracer delivery from plasma (12) . k 1 is mainly determined by mathematical fitting of the proximal portion of the tissue-time activity curve (with relation to arterial activity), and this is a key reason it is widely attributed to tracer delivery (12) . The third finding relates to interaction between delivery (k 1 ) and transport (k 3 ) in integrating the effect of insulin to govern rates of glucose uptake. Although values for k 1 did not change in response to insulin, whereas those for k 3 did increase during insulin-stimulated conditions, k 1 appeared to influence 3-[ 11 C]OMG uptake to a greater extent during insulin-stimulated than during basal conditions. This relationship between delivery and transport was best discerned in comparing soleus and anterior tibialis mus- cles. Insulin-stimulated uptake of 3-[ 11 C]OMG was significantly greater in soleus, and with regard to the individual rate constants the main difference from anterior tibialis was a higher value for k 1 but similar values for k 3 .
It is axiomatic that glucose must be transported into muscle before it can be oxidized, stored as glycogen, or otherwise metabolized. Clear dose-responsive insulin stimulation of muscle glucose metabolism is well established (13, 26) . Thus the finding of dose-responsive insulin stimulation of glucose transport in skeletal muscle of healthy volunteers is not unexpected. Nonetheless, there have been few prior human studies that have specifically examined this step. One clinical investigation that is perhaps the most specific was performed by Bonadonna et al. (4) and used a bolus injection of 3-[
14 C]OMG, given into the brachial artery, following which venous washout curves were measured across the forearm. The modeling of these data indicated a fourfold stimulation of glucose transport at supraphysiological insulin (4) . Although both the study by Bonadonna et al. and the current study evaluated skeletal muscle in humans by use of 3-OMG, data obtained by arteriovenous isotope washout and by PET imaging are not exactly the same, as PET measures tracer activity within the tissue bed itself. Despite this difference, there was similarity in findings in that in the current study the overall partition coefficient for 3-[
11 C]OMG uptake from plasma into tissue increased above basal three-and fourfold, respectively, at low physiological and supraphysiological elevations of insulin.
The rate constant k 3 delineates the fraction of tracer entering the second tissue compartment from the first, and it increased from 1% during Basal to 7 and 21% during LO and HI, respectively. This effect is consistent with the known effect of insulin to stimulate translocation of glucose transporter proteins in muscle (23) . In contrast, the rate constant k 1 , which describes the kinetics of 3-[
11 C]OMG delivery from plasma into the tissue bed of skeletal muscle, did not change in response to insulin. This finding is consistent with our earlier study using 3-[
11 C]OMG, in which it was also observed that k 1 did not change from basal values during midphysiological insulin stimulation (3 (1) . At low physiological elevations, increases of overall blood flow to muscle generally do not occur, but there may be an important effect to initiate capillary recruitment (9) . Unfortunately, measurement of capillary recruitment is beneath the spatial resolution of PET, since a pixel, the smallest divisible unit of PET imaging, can be estimated to contain thousands of muscle capillaries.
At first appraisal, the current findings of unchanged values for k 1 during insulin-stimulated compared with basal conditions might seem to indicate that glucose delivery is not a strong locus of control in the effect of insulin to govern rates of glucose uptake into muscle. However, our interpretation is different and is that, as insulin acts to increase glucose transport, glucose delivery emerges to have greater importance in governing glucose uptake than it exerts during basal conditions, when the kinetics of glucose transport are at their bottommost. Renkin et al. (22) postulated that the influence of substrate delivery upon its uptake is a function of tissue permeability and that flow is least likely to modulate substrate uptake when permeability is low. In this context, bidirectional transmembrane glucose transport functions as the permeability factor. Previous observations concerning the interaction of delivery and transport were based on experiments in a conscious rat model that also used 3-OMG and, like the current studies in humans, revealed interdependence of transport and delivery in control of glucose uptake (10, 11) . In those studies, the transsarcolemmal glucose gradient fell progressively with increasing insulin, as an increased efficiency of glucose transport brought extra-and intracellular glucose to closer equilibration and overall control of glucose uptake shifted toward rates of delivery (19) .
Comparison of 3-[ 11 C]OMG uptake into the tissue beds of soleus and tibialis anterior muscles provides further perspective on the interaction between delivery and transport and how this is potentially modulated by insulin. On the basis of ex vivo and animal studies, it is generally considered that oxidative muscle fibers have greater insulin sensitivity than glycolytic fibers (13) . This was observed in the current study, as insulinstimulated tissue activity of 3-[ 11 C]OMG was significantly higher in soleus than in tibialis anterior. Spectral analysis indicated that a similar two-exponential model was applicable to both muscles. In compartmental modeling of 3-[
11 C]OMG activity in the two muscles, values for k 3 were similar in soleus and tibialis anterior muscles during LO and HI insulin and therefore did not account for higher uptake of 3-[
11 C]OMG in soleus. Instead, the main difference between soleus and tibialis anterior was that k 1 was ϳ25% higher in soleus at midphysiological insulin and 33% higher at supraphysiological insulin. Although higher k 1 and, hence, presumably higher rates of delivery occur in soleus, the fact that the overall partition coefficient for the 3-[ 11 C]OMG was just 10% greater in soleus than in tibialis anterior suggests that rate control over glucose uptake is distributed between delivery and transport even at supraphysiological insulin stimulation.
In summary, bioimaging of skeletal muscle using dynamic PET imaging of the tracer 3-[
11 C]OMG provides a novel approach to assess glucose transport in human skeletal muscle. This method reveals clear dose-responsive insulin stimulation in healthy volunteers. This method begins to establish a technical feasibility for integrated physiology studies of the interdependence between glucose delivery and transport in mediating the action of insulin to govern glucose uptake into human skeletal muscle.
